Literature DB >> 25789102

Esophageal papilloma: Flexible endoscopic ablation by radiofrequency.

Gianmattia Del Genio1, Federica Del Genio1, Pietro Schettino1, Paolo Limongelli1, Salvatore Tolone1, Luigi Brusciano1, Manuela Avellino1, Chiara Vitiello1, Giovanni Docimo1, Angelo Pezzullo1, Ludovico Docimo1.   

Abstract

Squamous papilloma of the esophagus is a rare benign lesion of the esophagus. Radiofrequency ablation is an established endoscopic technique for the eradication of Barrett esophagus. No cases of endoscopic ablation of esophageal papilloma by radiofrequency ablation (RFA) have been reported. We report a case of esophageal papilloma successfully treated with a single session of radiofrequency ablation. Endoscopic ablation of the lesion was achieved by radiofrequency using a new catheter inserted through the working channel of endoscope. The esophageal ablated tissue was removed by a specifically designed cup. Complete ablation was confirmed at 3 mo by endoscopy with biopsies. This case supports feasibility and safety of as a new potential indication for Barrx(TM) RFA in patients with esophageal papilloma.

Entities:  

Keywords:  Endoscopic ablation; Esophageal papilloma; Minimally invasive; Natural orifice transluminal endoscopic surgery; Radiofrequency

Year:  2015        PMID： 25789102      PMCID： PMC4360450          DOI： 10.4253/wjge.v7.i3.290

Source DB:  PubMed          Journal:  World J Gastrointest Endosc


  13 in total

1.  Endoscopic mucosal resection of esophageal squamous papillomatosis.

Authors:  Edward Kim; Michael F Byrne; Fergal Donnellan
Journal:  Can J Gastroenterol       Date:  2012-11       Impact factor: 3.522

2.  Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study.

Authors:  K Nadine Phoa; Roos E Pouw; Frederike G I van Vilsteren; Carine M T Sondermeijer; Fiebo J W Ten Kate; Mike Visser; Sybren L Meijer; Mark I van Berge Henegouwen; Bas L A M Weusten; Erik J Schoon; Rosalie C Mallant-Hent; Jacques J G H M Bergman
Journal:  Gastroenterology       Date:  2013-03-28       Impact factor: 22.682

3.  Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial.

Authors:  Frederike G I van Vilsteren; Roos E Pouw; Stefan Seewald; Lorenza Alvarez Herrero; Carine M T Sondermeijer; Mike Visser; Fiebo J W Ten Kate; Karl C Yu Kim Teng; Nib Soehendra; Thomas Rösch; Bas L A M Weusten; Jacques J G H M Bergman
Journal:  Gut       Date:  2011-01-05       Impact factor: 23.059

4.  Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial.

Authors:  D E Fleischer; B F Overholt; V K Sharma; A Reymunde; M B Kimmey; R Chuttani; K J Chang; R Muthasamy; C J Lightdale; N Santiago; D K Pleskow; P J Dean; K K Wang
Journal:  Endoscopy       Date:  2010-09-20       Impact factor: 10.093

5.  Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia.

Authors:  Roos E Pouw; Katja Wirths; Pierre Eisendrath; Carine M Sondermeijer; Fiebo J Ten Kate; Paul Fockens; Jacques Devière; Horst Neuhaus; Jacques J Bergman
Journal:  Clin Gastroenterol Hepatol       Date:  2009-08-11       Impact factor: 11.382

6.  Radiofrequency ablation in Barrett's esophagus with dysplasia.

Authors:  Nicholas J Shaheen; Prateek Sharma; Bergein F Overholt; Herbert C Wolfsen; Richard E Sampliner; Kenneth K Wang; Joseph A Galanko; Mary P Bronner; John R Goldblum; Ana E Bennett; Blair A Jobe; Glenn M Eisen; M Brian Fennerty; John G Hunter; David E Fleischer; Virender K Sharma; Robert H Hawes; Brenda J Hoffman; Richard I Rothstein; Stuart R Gordon; Hiroshi Mashimo; Kenneth J Chang; V Raman Muthusamy; Steven A Edmundowicz; Stuart J Spechler; Ali A Siddiqui; Rhonda F Souza; Anthony Infantolino; Gary W Falk; Michael B Kimmey; Ryan D Madanick; Amitabh Chak; Charles J Lightdale
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

7.  Laparoscopic Nissen-Rossetti fundoplication with routine use of intraoperative endoscopy and manometry: technical aspects of a standardized technique.

Authors:  Gianmattia del Genio; Gianluca Rossetti; Luigi Brusciano; Paolo Limongelli; Francesco Pizza; Salvatore Tolone; Landino Fei; Vincenzo Maffettone; Vincenzo Napolitano; Alberto del Genio
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

8.  Photodynamic therapy vs radiofrequency ablation for Barrett's dysplasia: efficacy, safety and cost-comparison.

Authors:  Atilla Ertan; Irum Zaheer; Arlene M Correa; Nirav Thosani; Shanda H Blackmon
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

9.  Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial.

Authors:  K Nadine Phoa; Frederike G I van Vilsteren; Bas L A M Weusten; Raf Bisschops; Erik J Schoon; Krish Ragunath; Grant Fullarton; Massimiliano Di Pietro; Narayanasamy Ravi; Mike Visser; G Johan Offerhaus; Cees A Seldenrijk; Sybren L Meijer; Fiebo J W ten Kate; Jan G P Tijssen; Jacques J G H M Bergman
Journal:  JAMA       Date:  2014-03-26       Impact factor: 56.272

10.  Clinicopathological characteristics of esophageal squamous papillomas in Japanese patients--with comparison of findings from Western countries.

Authors:  Kuniko Takeshita; Shin-Ichi Murata; Shoji Mitsufuji; Naoki Wakabayashi; Keisho Kataoka; Yasunari Tsuchihashi; Takeshi Okanoue
Journal:  Acta Histochem Cytochem       Date:  2006-03-02       Impact factor: 1.938
View more
  2 in total

1.  Esophageal squamous papilloma lacks clear clinicopathological associations.

Authors:  Bilel Jideh; Martin Weltman; Yang Wu; Calvin H Y Chan
Journal:  World J Clin Cases       Date:  2017-04-16       Impact factor: 1.337

2.  A case report: Does the ulcer belong to esophageal carcinoma or HIV?

Authors:  Ning Jia; Yanping Tang; Yang Li; Yongkang Gan
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.